CPC A61K 39/0258 (2013.01) [A61K 39/0002 (2013.01); C12N 15/861 (2013.01); A61K 9/0019 (2013.01); A61K 2039/605 (2013.01); C12N 2770/16034 (2013.01)] | 19 Claims |
1. A method of increasing expression of a recombinant antigen in a dendritic host cell, comprising:
providing an adenovirus having a genome that includes a recombinant sequence encoding an antigen, wherein the sequence is operably linked to a promoter to drive expression of the antigen in the dendritic host cell;
providing a non-host cell, wherein the non-host cell is a Bacille Calmette Guerin, attenuated (BCG); and
ex vivo transfecting the recombinant adenovirus into the dendritic host cell;
wherein the step of ex vivo transfecting comprises concurrently exposing the dendritic host cell with both the adenovirus and the non-host cell under conditions to allow uptake of the virus into the host cell and to allow for expression of the recombinant sequence in the host cell;
wherein the exposure of the dendritic host cell with the non-host cell is in an amount that increases expression of the antigen in the dendritic cell as compared to exposure of the dendritic host cell with the adenovirus alone; and
wherein the dendritic host cell is transfected with BCG at an MOI (multiplicity of infection) of less than 5.0.
|